Beijing LabTech Instruments Co Stock

Beijing LabTech Instruments Co Revenue

The The revenue of Beijing LabTech Instruments Co (688056.SS) as of Jul 12, 2026 is 424.01 M CNY. In the previous year, The revenue was 416.00 M CNY — a change of 1.93% (higher).

Revenue

424.01 MCNY

YoY

1.93%

Last updated:

In 2026, Beijing LabTech Instruments Co's sales reached 424.01 M CNY, a 1.93% difference from the 416.00 M CNY sales recorded in the previous year.

Over the last 7 years Beijing LabTech Instruments Co grew revenue by 4.0% annually, reaching 424.01 M CNY.

The Beijing LabTech Instruments Co Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (M CNY)
GROSS MARGIN (%)
Date
REVENUE (M CNY)
GROSS MARGIN (%)
Jan 1, 2020
348.60 base
48.68 base
Jan 1, 2021
368.90 base
48.36 base
Jan 1, 2022
355.00 base
47.51 base
Jan 1, 2023
416.00 base
43.75 base
Jan 1, 2024
424.01 base
45.03 base
Jan 1, 2025 (e)
452.48 base
42.20 base
Jan 1, 2026 (e)
473.69 base
40.31 base
Jan 1, 2027 (e)
496.92 base
38.42 base
YEARREVENUE (M CNY)GROSS MARGIN (%)
2027 est 496.9238.42
2026 est 473.6940.31
2025 est 452.4842.20
2024 424.0145.03
2023 416.0043.75
2022 355.0047.51
2021 368.9048.36
2020 348.6048.68
2019 380.5046.28
2018 350.1048.24
2017 322.1051.82
Access this data via the Eulerpool API

Beijing LabTech Instruments Co Revenue

Beijing LabTech Instruments Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
348.60 M CNY
68.30 M CNY
65.20 M CNY
Jan 1, 2021
368.90 M CNY
68.10 M CNY
69.40 M CNY
Jan 1, 2022
355.00 M CNY
43.30 M CNY
44.62 M CNY
Jan 1, 2023
416.00 M CNY
26.30 M CNY
27.56 M CNY
Jan 1, 2024
424.01 M CNY
43.77 M CNY
39.15 M CNY
Jan 1, 2025 (e)
452.48 M CNY
58.58 M CNY
50.41 M CNY
Jan 1, 2026 (e)
473.69 M CNY
83.83 M CNY
58.59 M CNY
Jan 1, 2027 (e)
496.92 M CNY
99.99 M CNY
67.44 M CNY

Beijing LabTech Instruments Co Margins

Beijing LabTech Instruments Co stock margins

The Beijing LabTech Instruments Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Beijing LabTech Instruments Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Beijing LabTech Instruments Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
48.68 %
19.59 %
18.70 %
Jan 1, 2021
48.36 %
18.46 %
18.81 %
Jan 1, 2022
47.51 %
12.20 %
12.57 %
Jan 1, 2023
43.75 %
6.32 %
6.63 %
Jan 1, 2024
45.03 %
10.32 %
9.23 %
Jan 1, 2025 (e)
45.03 %
12.95 %
11.14 %
Jan 1, 2026 (e)
45.03 %
17.70 %
12.37 %
Jan 1, 2027 (e)
45.03 %
20.12 %
13.57 %

Beijing LabTech Instruments Co Stock analysis

What does Beijing LabTech Instruments Co do? Beijing LabTech Instruments Co is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Beijing LabTech Instruments Co's Sales Figures

The sales figures of Beijing LabTech Instruments Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Beijing LabTech Instruments Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Beijing LabTech Instruments Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Beijing LabTech Instruments Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Beijing LabTech Instruments Co stock

The revenue of Beijing LabTech Instruments Co is 424.01 M CNY in 2026.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Beijing LabTech Instruments Co

All Key Metrics — Beijing LabTech Instruments Co